Search - tctmd.com

Displaying 261 - 280 of 341

Sort: Relevancy | Date

News Daily News

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Jason Kahn

January 01, 2014

News Daily News

Más Gasto en Pacientes EAP No arroja Beneficio alguno en los Índices de Amputación

December 05, 2013

News Daily News

Higher Spending in PAD Patients Yields No Benefit in Amputation Rates

December 05, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Industry News

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

October 29, 2013

News Industry News

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

October 28, 2013

News Industry News

Boston Scientific Reports Favorable Clinical Trial Results Assessing The OffRoad™ Re-Entry Catheter System

October 11, 2013

News Industry News

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System

October 09, 2013

News Daily News

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Yael L. Maxwell

September 27, 2013

News Industry News

Boston Scientific Completes Enrollment In SuperNOVA Trial Evaluating Innova™ Self-Expanding Stent System

August 19, 2013

News Daily News

Risk Model Predicts 30-Day Readmissions After PCI

Jason Kahn

July 12, 2013

News Daily News

Morbid Obesity: An Increasing Risk Factor in PCI Patients

L.A. McKeown

June 20, 2013

News Industry News

New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System

May 22, 2013

News Daily News

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

April 26, 2013

News Daily News

Subestudio ACT: La NAC No Reduce el Daño Renal en los Pacientes Diabéticos

April 19, 2013

News Daily News

Stent Grafts Better Than Angioplasty for Failing Dialysis-Access Grafts

Jason Kahn

April 19, 2013

News Daily News

ACT Substudy: NAC Does Not Reduce Kidney Damage in Diabetic Patients

April 19, 2013

News Daily News

Pair of Studies Support Paclitaxel-Eluting Devices for Treating Femoropopliteal Disease

Caitlin E. Cox

April 05, 2013

News Daily News

2 Estudios Avalan el Uso de Dispositivos liberadores de Paclitaxel en el Tratamiento de la Enfermedad Femoropoplítea

Caitlin E. Cox

April 05, 2013

News Daily News

Most Hospital Readmissions Within 30 Days of PCI Unrelated to Index Procedure

March 28, 2013

Advertisement

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Más Gasto en Pacientes EAP No arroja Beneficio alguno en los Índices de Amputación

Higher Spending in PAD Patients Yields No Benefit in Amputation Rates

Innovation in Intervention: Perspectives from Industry

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

Boston Scientific Reports Favorable Clinical Trial Results Assessing The OffRoad™ Re-Entry Catheter System

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Boston Scientific Completes Enrollment In SuperNOVA Trial Evaluating Innova™ Self-Expanding Stent System

Risk Model Predicts 30-Day Readmissions After PCI

Morbid Obesity: An Increasing Risk Factor in PCI Patients

New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

Subestudio ACT: La NAC No Reduce el Daño Renal en los Pacientes Diabéticos

Stent Grafts Better Than Angioplasty for Failing Dialysis-Access Grafts

ACT Substudy: NAC Does Not Reduce Kidney Damage in Diabetic Patients

Pair of Studies Support Paclitaxel-Eluting Devices for Treating Femoropopliteal Disease

2 Estudios Avalan el Uso de Dispositivos liberadores de Paclitaxel en el Tratamiento de la Enfermedad Femoropoplítea

Most Hospital Readmissions Within 30 Days of PCI Unrelated to Index Procedure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content